Departement
Klinische Forschung
Achtung: Diese Seite kann nur von Administratoren besucht werden, da Sie nicht freigeschalten wurde.
Zurück
Publications Hartmann Karin

Clinical Impact of Skin Lesions in Mastocytosis: A Multicenter Study of the European Competence Network on Mastocytosis (ECNM).

Aberer E; Sperr WR; Bretterklieber A; Avian A; Hadzijusufovic E; Kluin-Nelemans HC; Elberink HO; van Anrooij B; Niedoszytko M; Lange M; Górska A; Elena C; Brazzelli V; Fortina AB; Caroppo F; Hartmann K; Illerhaus A; Reiter A; Jawhar M; Bonadonna P; Zanotti R; Triggiani M; Parente R; Gotlib J; Doubek M; von Bubnoff N; Fuchs D; Sabato V; Brockow K; Jäkel N; Panse J; Valent P. The Journal of investigative dermatology. 2021.

COVID-19 infection in patients with mast cell disorders including mastocytosis does not impact mast cell activation symptoms.

Giannetti MP; Weller E; Alvarez-Twose I; Torrado I; Bonadonna P; Zanotti R; Dwyer DF; Foer D; Akin C; Hartmann K; Rama TA; Sperr WR; Valent P; Teodosio C; Orfao A; Castells M. The journal of allergy and clinical immunology. In practice. 2021.

COVID-19 vaccination in mastocytosis: recommendations of the European Competence Network on Mastocytosis (ECNM) and American Initiative in Mast Cell Diseases (AIM).

Bonadonna P; Brockow K; Niedoszytko M; Elberink HO; Akin C; Nedoszytko B; Butterfield JH; Alvarez-Twose I; Sotlar K; Schwaab J; Jawhar M; Castells M; Sperr WR; Hermine O; Gotlib J; Zanotti R; Reiter A; Broesby-Olsen S; Bindslev-Jensen C; Schwartz LB; Horny HP; Radia D; Triggiani M; Sabato V; Carter MC; Siebenhaar F; Orfao A; Grattan C; Metcalfe DD; Arock M; Gulen T; Hartmann K; Valent P. The journal of allergy and clinical immunology. In practice. 2021.

Cytogenetic and molecular aberrations and worse outcome for male patients in systemic mastocytosis.

Kluin-Nelemans HC; Jawhar M; Reiter A; van Anrooij B; Gotlib J; Hartmann K; Illerhaus A; Oude Elberink HNG; Gorska A; Niedoszytko M; Lange M; Scaffidi L; Zanotti R; Bonadonna P; Perkins C; Elena C; Malcovati L; Shoumariyeh K; von Bubnoff N; Müller S; Triggiani M; Parente R; Schwaab J; Kundi M; Fortina AB; Caroppo F; Brockow K; Zink A; Fuchs D; Angelova-Fischer I; Yavuz AS; Doubek M; Mattsson M; Hagglund H; Panse J; Simonowski A; Sabato V; Schug T; Jentzsch M; Breynaert C; Várkonyi J; Kennedy V; Hermine O; Rossignol J; Arock M; Valent P; Sperr WR. Theranostics. 2021.

Detection of the germline KIT S476I mutation in a kindred with familial mastocytosis associated with gastrointestinal stromal tumors.

Peters F; Fiebig B; Lundberg P; Jaspers NI; Holzapfel B; Ghadimi MPH; Drebber U; Tuchscherer A; Ullrich R; Hartmann K; Tantcheva-Poór I. The journal of allergy and clinical immunology. In practice. 2021.

Expression of PD-1 and Tim-3 is increased in skin of patients with bullous pemphigoid and pemphigus vulgaris.

Ernst N; Friedrich M; Bieber K; Kasperkiewicz M; Gross N; Sadik CD; Zillikens D; Schmidt E; Ludwig RJ; Hartmann K. Journal of the European Academy of Dermatology and Venereology : JEADV. 2021.

Management of Hypersensitivity Reactions to Nondextran Iron Products: New Insights Into Predisposing Risk Factors.

Steveling-Klein EH; Mateluna CM; Meienberg A; Hartmann K; Bircher A; Scherer Hofmeier K. The journal of allergy and clinical immunology. In practice. 2021.

Molecular Background, Clinical Features and Management of Pediatric Mastocytosis: Status 2021.

Lange M; Hartmann K; Carter MC; Siebenhaar F; Alvarez-Twose I; Torrado I; Brockow K; Renke J; Irga-Jaworska N; Plata-Nazar K; Ługowska-Umer H; Czarny J; Belloni Fortina A; Caroppo F; Nowicki RJ; Nedoszytko B; Niedoszytko M; Valent P. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2021.

Practical management of adverse events in patients with advanced systemic mastocytosis receiving midostaurin.

Gotlib J; Kluin-Nelemans HC; Akin C; Hartmann K; Valent P; Reiter A. EXPERT OPINION ON BIOLOGICAL THERAPY. 2021.

Severe allergic reactions after COVID-19 vaccination with the Pfizer/BioNTech vaccine in Great Britain and USA: Position statement of the German Allergy Societies: Medical Association of German Allergologists (AeDA), German Society for Allergology and Clinical Immunology (DGAKI) and Society for Pediatric Allergology and Environmental Medicine (GPA).

Klimek L; Novak N; Hamelmann E; Werfel T; Wagenmann M; Taube C; Bauer A; Merk H; Rabe U; Jung K; Schlenter W; Ring J; Chaker A; Wehrmann W; Becker S; Mülleneisen N; Nemat K; Czech W; Wrede H; Brehler R; Fuchs T; Jakob T; Ankermann T; Schmidt SM; Gerstlauer M; Vogelberg C; Zuberbier T; Hartmann K; Worm M. Allergo journal international. 2021.

Structured diagnostic assessment of hand eczema in cleaning workers.

Jamiolkowski D; Steveling-Klein E; Thomas ZM; Bircher A; Hofmeier KS; Hartmann K. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG. 2021.

Activation of Siglec-7 results in inhibition of in vitro and in vivo growth of human mast cell leukemia cells.

Landolina N; Zaffran I; Smiljkovic D; Serrano-Candelas E; Schmiedel D; Friedman S; Arock M; Hartmann K; Pikarsky E; Mandelboim O; Martin M; Valent P; Levi-Schaffer F. PHARMACOLOGICAL RESEARCH. 2020.

AllergoOncology: ultra-low IgE, a potential novel biomarker in cancer-a Position Paper of the European Academy of Allergy and Clinical Immunology (EAACI).

Ferastraoaru D; Bax HJ; Bergmann C; Capron M; Castells M; Dombrowicz D; Fiebiger E; Gould HJ; Hartmann K; Jappe U; Jordakieva G; Josephs DH; Levi-Schaffer F; Mahler V; Poli A; Rosenstreich D; Roth-Walter F; Shamji M; Steveling-Klein EH; Turner MC; Untersmayr E; Karagiannis SN; Jensen-Jarolim E. Clinical and Translational Allergy. 2020.

Clinical features and survival of patients with indolent systemic mastocytosis defined by the updated WHO classification.

Trizuljak J; Sperr WR; Nekvindová L; Elberink HO; Gleixner KV; Gorska A; Lange M; Hartmann K; Illerhaus A; Bonifacio M; Perkins C; Elena C; Malcovati L; Fortina AB; Shoumariyeh K; Jawhar M; Zanotti R; Bonadonna P; Caroppo F; Zink A; Triggiani M; Parente R; von Bubnoff N; Yavuz AS; Hägglund H; Mattsson M; Panse J; Jäkel N; Kilbertus A; Hermine O; Arock M; Fuchs D; Sabato V; Brockow K; Bretterklieber A; Niedoszytko M; van Anrooij B; Reiter A; Gotlib J; Kluin-Nelemans HC; Mayer J; Doubek M; Valent P. ALLERGY. 2020.

Diagnosis, Classification and Management of Mast Cell Activation Syndromes (MCAS) in the Era of Personalized Medicine.

Valent P; Akin C; Nedoszytko B; Bonadonna P; Hartmann K; Niedoszytko M; Brockow K; Siebenhaar F; Triggiani M; Arock M; Romantowski J; Górska A; Schwartz LB; Metcalfe DD. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2020.

Emerging treatments in COVID-19: Adverse drug reactions including drug hypersensitivities.

Manjaly Thomas ZR; Leuppi-Taegtmeyer A; Jamiolkowski D; Steveling-Klein E; Bellutti-Enders F; Scherer Hofmeier K; Hartmann K. . 2020.

Healthcare provision for insect venom allergy patients during the COVID-19 pandemic.

Worm M; Ballmer-Weber B; Brehler R; Cuevas M; Gschwend A; Hartmann K; Hawranek T; Hötzenecker W; Homey B; Jakob T; Novak N; Pickert J; Saloga J; Schäkel K; Trautmann A; Treudler R; Wedi B; Sturm G; Rueff F. Allergo journal international. 2020.

History and Current Status of Mastocytosis Research in the European Competence Network on Mastocytosis

Valent P; Arock M; Hadzijusufovic E; Sperr WR; Hartmann K; Akin C; Metcalfe DD; Horny HP. . 2020.

Mast cells as a unique hematopoietic lineage and cell system: From Paul Ehrlich's visions to precision medicine concepts.

Valent P; Akin C; Hartmann K; Nilsson G; Reiter A; Hermine O; Sotlar K; Sperr WR; Escribano L; George TI; Kluin-Nelemans HC; Ustun C; Triggiani M; Brockow K; Gotlib J; Orfao A; Kovanen PT; Hadzijusufovic E; Sadovnik I; Horny HP; Arock M; Schwartz LB; Austen KF; Metcalfe DD; Galli SJ. Theranostics. 2020.

Midostaurin improves quality of life and mediator-related symptoms in advanced systemic mastocytosis.

Hartmann K; Gotlib J; Akin C; Hermine O; Awan FT; Hexner E; Mauro MJ; Menssen HD; Redhu S; Knoll S; Sotlar K; George TI; Horny HP; Valent P; Reiter A; Kluin-Nelemans HC. The Journal of allergy and clinical immunology. 2020.

Multilocular bullous fixed drug eruption elicited by paracetamol and migraine attacks, but not by paracetamol alone.

Jamiolkowski D; Steveling-Klein E; Scherer Hofmeier K; Hartmann K. CONTACT DERMATITIS. 2020.

Natatorial mishap: Skin lesions caused by jellyfish stings.

Neumann K; Niemer M; Wildt C; Anemüller W; Zillikens D; Hartmann K. . 2020.

New developments in the field of mastocytosis and mast cell activation syndromes: a summary of the Annual Meeting of the European Competence Network on Mastocytosis (ECNM) 2019.

Arock M; Sotlar K; Gotlib J; Sperr WR; Hartmann K; Schwartz LB; Akin C; Horny HP; Valent P. . 2020.

Prognostic impact of eosinophils in mastocytosis: analysis of 2350 patients collected in the ECNM Registry.

Kluin-Nelemans HC; Reiter A; Illerhaus A; van Anrooij B; Hartmann K; Span LFR; Gorska A; Niedoszytko M; Lange M; Scaffidi L; Zanotti R; Bonadonna P; Perkins C; Elena C; Malcovati L; Shoumariyeh K; von Bubnoff N; Parente R; Triggiani M; Schwaab J; Jawhar M; Caroppo F; Fortina AB; Brockow K; Zink A; Fuchs D; Kilbertus A; Yavuz AS; Doubek M; Mattsson M; Hagglund H; Panse J; Sabato V; Aberer E; Niederwieser D; Breynaert C; Várkonyi J; Kennedy V; Lortholary O; Jakob T; Hermine O; Rossignol J; Arock M; Gotlib J; Valent P; Sperr WR. Leukemia. 2020.

Risk and management of patients with mastocytosis and MCAS in the SARS-CoV-2 (COVID-19) pandemic: Expert opinions.

Valent P; Akin C; Bonadonna P; Brockow K; Niedoszytko M; Nedoszytko B; Butterfield JH; Alvarez-Twose I; Sotlar K; Schwaab J; Jawhar M; Reiter A; Castells M; Sperr WR; Kluin-Nelemans HC; Hermine O; Gotlib J; Zanotti R; Broesby-Olsen S; Horny HP; Triggiani M; Siebenhaar F; Orfao A; Metcalfe DD; Arock M; Hartmann K. The Journal of allergy and clinical immunology. 2020.

Scoring the Risk of Having Systemic Mastocytosis in Adult Patients with Mastocytosis in the Skin.

Fuchs D; Kilbertus A; Kofler K; von Bubnoff N; Shoumariyeh K; Zanotti R; Bonadonna P; Scaffidi L; Doubek M; Elberink HO; Span LFR; Hermine O; Elena C; Benvenuti P; Yavuz AS; Brockow K; Zink A; Aberer E; Gorska A; Romantowski J; Hadzijusufovic E; Fortina AB; Caroppo F; Perkins C; Illerhaus A; Panse J; Vucinic V; Jawhar M; Sabato V; Triggiani M; Parente R; Bergström A; Breynaert C; Gotlib J; Reiter A; Hartmann K; Niedoszytko M; Arock M; Kluin-Nelemans HC; Sperr WR; Greul R; Valent P. The journal of allergy and clinical immunology. In practice. 2020.

Travel-associated infectious skin diseases.

Rongisch R; Schmidt E; Deresz N; Deresz K; Schöfer H; Schäkel K; Jakob T; Maurer M; Sticherling M; Sunderkötter C; Babilas P; Spornraft-Ragaller P; Traidl-Hoffmann C; Gläser R; Hartmann K; Kolb-Mäurer A; Wenzel J; Biedermann T; Homey B; Pfützner W; Weid F; Fischer M; Linder R; von Stebut E. . 2020.

Urticaria: Collegium Internationale Allergologicum (CIA) Update 2020.

Maurer M; Eyerich K; Eyerich S; Ferrer M; Gutermuth J; Hartmann K; Jakob T; Kapp A; Kolkhir P; Larenas-Linnemann D; Park HS; Pejler G; Sánchez-Borges M; Schäkel K; Simon D; Simon HU; Weller K; Zuberbier T; Metz M. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY. 2020.

Utility and risk of dermatologic medications during the COVID-19 pandemic.

Goldust M; Hartmann K; Abdelmaksoud A; Navarini AA. Dermatologic Therapy. 2020.

AllergoOncology: Microbiota in allergy and cancer—A European Academy for Allergy and Clinical Immunology position paper

Untersmayr E.; Bax H.J.; Bergmann C.; Bianchini R.; Cozen W.; Gould H.J.; Hartmann K.; Josephs D.H.; Levi-Schaffer F.; Penichet M.L.; O'Mahony L.; Poli A.; Redegeld F.A.; Roth-Walter F.; Turner M.C.; Vangelista L.; Karagiannis S.N.; Jensen-Jarolim E.. ALLERGY. 2019.

Guideline: Hereditary angioedema due to C1 inhibitor deficiency: S1 Guideline of the German Society for Angioedema (Deutsche Gesellschaft für Angioödeme, DGA), German Society for Internal Medicine (Deutsche Gesellschaft für Innere Medizin, DGIM), German Society for Otorhinolaryngology (Deutsche Gesellschaft für Hals-Nasen-Ohren-Heilkunde, DGHNO), German Society for Allergology and Clinical Immunology (Deutsche Gesellschaft für Allergologie und klinische Immunologie, DGAKI), German Society for Child and Adolescent Medicine (Deutsche Gesellschaft für Kinder- und Jugendmedizin, DGKJ), German Dermatological Society (Deutsche Dermatologische Gesellschaft, DDG), German Society for Pediatric Allergology and Environmental Medicine (Gesellschaft für Pädiatrische Allergologie und Umweltmedizin, GPA), German Association of ENT Surgeons (Deutscher Berufsverband der Hals-Nasen-Ohren-Ärzte, BVHNO), and the German HAE Patient Association (HAE-Vereinigung, Selbsthilfegruppe, HAE-SHG)

Bork K.; Aygoren-Pursun E.; Bas M.; Biedermann T.; Greve J.; Hartmann K.; Magerl M.; Martinez-Saguer I.; Maurer M.; Ott H.; Schauf L.; Staubach P.; Wedi B.. Allergo journal international. 2019.

Hereditary angioedema due to C1 inhibitor deficiency Hereditäres Angioödem durch C1-Inhibitor-Mangel

Bork K.; Aygoren-Pursun E.; Bas M.; Biedermann T.; Greve J.; Hartmann K.; Magerl M.; Martinez-Saguer I.; Maurer M.; Ott H.; Schauf L.; Staubach P.; Wedi B.. ALLERGOLOGIE. 2019.

Identification of the recently described plasminogen gene mutation p.Lys330Glu in a family from Northern Germany with hereditary angioedema.

Recke A; Massalme EG; Jappe U; Steinmüller-Magin L; Schmidt J; Hellenbroich Y; Hüning I; Gillessen-Kaesbach G; Zillikens D; Hartmann K. Clinical and Translational Allergy. 2019.

International prognostic scoring system for mastocytosis (IPSM): a retrospective cohort study.

Sperr WR; Kundi M; Alvarez-Twose I; van Anrooij B; Oude Elberink JNG; Gorska A; Niedoszytko M; Gleixner KV; Hadzijusufovic E; Zanotti R; Bonadonna P; Bonifacio M; Perkins C; Illerhaus A; Elena C; Merante S; Shoumariyeh K; von Bubnoff N; Parente R; Jawhar M; Belloni Fortina A; Caroppo F; Brockow K; Zink A; Fuchs D; Kilbertus AJ; Yavuz AS; Doubek M; Hägglund H; Panse J; Sabato V; Bretterklieber A; Niederwieser D; Breynaert C; Hartmann K; Triggiani M; Nedoszytko B; Reiter A; Orfao A; Hermine O; Gotlib J; Arock M; Kluin-Nelemans HC; Valent P. Lancet Haematology. 2019.

Mast cell activation in Dowling-Degos disease.

Knuever J; Persa OD; Illerhaus A; Ralser DJ; Hartmann K; Betz RC; Tantcheva-Poór I. . 2019.

Modulation of Mast Cell Reactivity by Lipids: The Neglected Side of Allergic Diseases.

Hagemann PM; Nsiah-Dosu S; Hundt JE; Hartmann K; Orinska Z. Frontiers in Immunology. 2019.

PD-L1 Expression in Mastocytosis.

Williams M; Lidke DS; Hartmann K; George TI. International Journal of Molecular Sciences. 2019.

Proposed Diagnostic Algorithm for Patients with Suspected Mast Cell Activation Syndrome

Valent P.; Akin C.; Bonadonna P.; Hartmann K.; Brockow K.; Niedoszytko M.; Nedoszytko B.; Siebenhaar F.; Sperr W.R.; Oude Elberink J.N.G.; Butterfield J.H.; Alvarez-Twose I.; Sotlar K.; Reiter A.; Kluin-Nelemans H.C.; Hermine O.; Gotlib J.; Broesby-Olsen S.; Orfao A.; Horny H.-P.; Triggiani M.; Arock M.; Schwartz L.B.; Metcalfe D.D.. The journal of allergy and clinical immunology. In practice. 2019.

Skin disease in mastocytosis

Manjaly Thomas Z-R; Hartmann K. . 2019.

Targeting tumor-resident mast cells for effective anti-melanoma immune responses.

Kaesler S; Wölbing F; Kempf WE; Skabytska Y; Köberle M; Volz T; Sinnberg T; Amaral T; Möckel S; Yazdi A; Metzler G; Schaller M; Hartmann K; Weide B; Garbe C; Rammensee HG; Röcken M; Biedermann T. JCI insight. 2019.

The Data Registry of the European Competence Network on Mastocytosis (ECNM): Set Up, Projects, and Perspectives

Valent P.; Oude Elberink J.N.G.; Gorska A.; Lange M.; Zanotti R.; van Anrooij B.; Bonifacio M.; Bonadonna P.; Gleixner K.V.; Hadzijusufovic E.; Perkins C.; Hartmann K.; Illerhaus A.; Merante S.; Elena C.; Shoumariyeh K.; von Bubnoff N.; Parente R.; Triggiani M.; Schwaab J.; Jawhar M.; Caroppo F.; Fortina A.B.; Brockow K.; David Fuchs; Greul R.; Yavuz A.S.; Doubek M.; Mattsson M.; Hagglund H.; Panse J.; Sabato V.; Aberer E.; Al-Ali H.K.; Morren M.-A.; Varkonyi J.; Zink A.; Niedoszytko M.; Niederwieser D.; Malcovati L.; Reiter A.; Kennedy V.; Gotlib J.; Lortholary O.; Hermine O.; Arock M.; Kluin-Nelemans H.; Sperr W.R.. The journal of allergy and clinical immunology. In practice. 2019.

Why the 20% + 2 Tryptase Formula Is a Diagnostic Gold Standard for Severe Systemic Mast Cell Activation and Mast Cell Activation Syndrome.

Valent P; Bonadonna P; Hartmann K; Broesby-Olsen S; Brockow K; Butterfield JH; Triggiani M; Lyons JJ; Oude Elberink JNG; Arock M; Metcalfe DD; Akin C. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY. 2019.

Although Abundant in Tumor Tissue, Mast Cells Have No Effect on Immunological Micro-milieu or Growth of HPV-Induced or Transplanted Tumors

Ghouse S.M.; Polikarpova A.; Muhandes L.; Dudeck J.; Tantcheva-Poor I.; Hartmann K.; Lesche M.; Dahl A.; Eming S.; Muller W.; Behrendt R.; Roers A.. Cell Reports. 2018.

Cutaneous mastocytosis

Hartmann K; Valent P; Horny HP. . 2018.

Eosinophils are a major source of interleukin-31 in bullous pemphigoid

Rudrich U.; Gehring M.; Papakonstantinou E.; Illerhaus A.; Engmann J.; Kapp A.; Hartmann K.; Meyer N.H.; Gibbs B.F.; Raap U.. ACTA DERMATO-VENEREOLOGICA. 2018.

Mast cell activation syndrome: Importance of consensus criteria and call for research

Valent P.; Akin C.; Bonadonna P.; Hartmann K.; Broesby-Olsen S.; Brockow K.; Butterfield J.H.; Reiter A.; Gotlib J.; Castells M.; Milner J.D.; Carter M.C.; Komarow H.; Radia D.; Pardanani A.; Sotlar K.; Triggiani M.; Horny H.-P.; Arock M.; Schwartz L.B.; Metcalfe D.D.. The Journal of allergy and clinical immunology. 2018.

Mast Cell-Specific Expression of Human Siglec-8 in Conditional Knock-in Mice.

Wei Y; Chhiba KD; Zhang F; Ye X; Wang L; Zhang L; Robida PA; Moreno-Vinasco L; Schnaar RL; Roers A; Hartmann K; Lee CM; Demers D; Zheng T; Bochner BS; Zhu Z. International Journal of Molecular Sciences. 2018.

Mouse mast cells and mast cell proteases do not play a significant role in acute tissue injury pain induced by formalin

Magnusdottir E.I.; Grujic M.; Roers A.; Hartmann K.; Pejler G.; Lagerstrom M.C.. Molecular Pain. 2018.

Normocomplementaemic urticarial vasculitis: Effective treatment with omalizumab

De Brito M.; Huebner G.; Murrell D.; Bullpitt P.; Hartmann K.. Clinical and Translational Allergy. 2018.

Preclinical human models and emerging therapeutics for advanced systemic mastocytosis

Arock M.; Wedeh G.; Hoermann G.; Bibi S.; Akin C.; Peter B.; Gleixner K.V.; Hartmann K.; Butterfield J.H.; Metcalfe D.D.; Valent P.. Haematologica. 2018.

The Role of Mast Cells in Autoimmune Bullous Dermatoses.

Yu X; Kasprick A; Hartmann K; Petersen F. Frontiers in Immunology. 2018.

Variability of PD-L1 expression in mastocytosis.

Hatch EW; Geeze MB; Martin C; Salama ME; Hartmann K; Eisenwort G; Blatt K; Valent P; Gotlib J; Lee JH; Chen L; Ward HH; Lidke DS; George TI. Blood advances. 2018.

Advances in the classification and treatment of mastocytosis: Current status and outlook toward the future

Valent P.; Akin C.; Hartmann K.; Nilsson G.; Reiter A.; Hermine O.; Sotlar K.; Sperr W.R.; Escribano L.; George T.I.; Kluin-Nelemans H.C.; Ustun C.; Triggiani M.; Brockow K.; Gotlib J.; Orfao A.; Schwartz L.B.; Broesby-Olsen S.; Bindslev-Jensen C.; Kovanen P.T.; Galli S.J.; Austen K.F.; Arber D.A.; Horny H.-P.; Arock M.; Metcalfe D.D.. Cancer research. 2017.

Midostaurin: a magic bullet that blocks mast cell expansion and activation.

Valent P; Akin C; Hartmann K; George TI; Sotlar K; Peter B; Gleixner KV; Blatt K; Sperr WR; Manley PW; Hermine O; Kluin-Nelemans HC; Arock M; Horny HP; Reiter A; Gotlib J. Annals of oncology : official journal of the European Society for Medical Oncology. 2017.

Proposed diagnostic criteria and classification of basophilic leukemias and related disorders

Valent P.; Sotlar K.; Blatt K.; Hartmann K.; Reiter A.; Sadovnik I.; Sperr W.R.; Bettelheim P.; Akin C.; Bauer K.; George T.I.; Hadzijusufovic E.; Wolf D.; Gotlib J.; Mahon F.-X.; Metcalfe D.D.; Horny H.-P.; Arock M.. Leukemia. 2017.

111 Top-Lernziele Dermatologie: Lernzielkatalog für Haut- und Geschlechtskrankheiten der Deutschen Dermatologischen Gesellschaft.

Ochsendorf F; Bandholz T; Emmert S; Hartmann K; Hartmann M; Hornung T; Jünger M; Kollewe T; Löser C; Moll I; Psotta-Schachtner C; Spornraft-Ragaller P; Ständer S; von Stebut-Borschitz E; Hamm H. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG. 2016.

Advanced systemic mastocytosis: From molecular and genetic progress to clinical practice

Ustun C.; Arock M.; Kluin-Nelemans H.C.; Reiter A.; Sperr W.R.; George T.; Horny H.-P.; Hartmann K.; Sotlar K.; Damaj G.; Hermine O.; Verstovsek S.; Metcalfe D.D.; Gotlib J.; Akin C.; Valent P.. Haematologica. 2016.

Cutaneous manifestations in patients with mastocytosis: Consensus report of the European Competence Network on Mastocytosis; the American Academy of Allergy, Asthma & Immunology; and the European Academy of Allergology and Clinical Immunology.

Hartmann K; Escribano L; Grattan C; Brockow K; Carter MC; Alvarez-Twose I; Matito A; Broesby-Olsen S; Siebenhaar F; Lange M; Niedoszytko M; Castells M; Oude Elberink JNG; Bonadonna P; Zanotti R; Hornick JL; Torrelo A; Grabbe J; Rabenhorst A; Nedoszytko B; Butterfield JH; Gotlib J; Reiter A; Radia D; Hermine O; Sotlar K; George TI; Kristensen TK; Kluin-Nelemans HC; Yavuz S; Hägglund H; Sperr WR; Schwartz LB; Triggiani M; Maurer M; Nilsson G; Horny HP; Arock M; Orfao A; Metcalfe DD; Akin C; Valent P. The Journal of allergy and clinical immunology. 2016.

Development and validation of the mastocytosis quality of life questionnaire: MC-QoL.

Siebenhaar F; von Tschirnhaus E; Hartmann K; Rabenhorst A; Staubach P; Peveling-Oberhag A; Wagner N; Martus P; Carter MC; Metcalfe DD; Church MK; Maurer M; Weller K. ALLERGY. 2016.

Efficacy and Safety of Midostaurin in Advanced Systemic Mastocytosis.

Gotlib J; Kluin-Nelemans HC; George TI; Akin C; Sotlar K; Hermine O; Awan FT; Hexner E; Mauro MJ; Sternberg DW; Villeneuve M; Huntsman Labed A; Stanek EJ; Hartmann K; Horny HP; Valent P; Reiter A. The New England journal of medicine. 2016.

Expression of programmed cell death ligand-1 in mastocytosis correlates with disease severity

Rabenhorst A.; Leja S.; Schwaab J.; Gehring M.; Forster A.; Arock M.; Reiter A.; Raap U.; Hartmann K.. The Journal of allergy and clinical immunology. 2016.

In Vivo Expansion of Endogenous Regulatory T Cell Populations Induces Long-Term Suppression of Contact Hypersensitivity.

El Beidaq A; Link CW; Hofmann K; Frehse B; Hartmann K; Bieber K; Martin SF; Ludwig RJ; Manz RA. JOURNAL OF IMMUNOLOGY. 2016.

Mast cells promote melanoma colonization of lungs

Ohrvik H.; Grujic M.; Waern I.; Gustafson A.-M.; Ernst N.; Roers A.; Hartmann K.; Pejler G.. Oncotarget. 2016.

Activation of KIT modulates the function of tumor necrosis factor-related apoptosis-inducing ligand receptor (TRAIL-R) in mast cells

Forster A.; Grotha S.P.; Seeger J.M.; Rabenhorst A.; Gehring M.; Raap U.; Letard S.; Dubreuil P.; Kashkar H.; Walczak H.; Roers A.; Hartmann K.. ALLERGY. 2015.

Conditional depletion of mast cells has no impact on the severity of experimental epidermolysis bullosa acquisita.

Kasprick A; Yu X; Scholten J; Hartmann K; Pas HH; Zillikens D; Ludwig RJ; Petersen F. EUROPEAN JOURNAL OF IMMUNOLOGY. 2015.

Dicer is indispensable for the development of murine mast cells: To the editor

Forster A.; Blissenbach B.; Machova A.; Leja S.; Rabenhorst A.; Wilmschen S.; Heger K.; Schmidt-Supprian M.; Roers A.; Hartmann K.; Papadopoulou N.. The Journal of allergy and clinical immunology. 2015.

KIT mutation analysis in mast cell neoplasms: Recommendations of the European Competence Network on Mastocytosis

Arock M.; Sotlar K.; Akin C.; Broesby-Olsen S.; Hoermann G.; Escribano L.; Kristensen T.K.; Kluin-Nelemans H.C.; Hermine O.; Dubreuil P.; Sperr W.R.; Hartmann K.; Gotlib J.; Cross N.C.P.; Haferlach T.; Garcia-Montero A.; Orfao A.; Schwaab J.; Triggiani M.; Horny H.-P.; Metcalfe D.D.; Reiter A.; Valent P.. Leukemia. 2015.

Large maculopapular cutaneous lesions are associated with favorable outcome in childhood-onset mastocytosis

Wiechers T.; Rabenhorst A.; Schick T.; Preussner L.M.; Forster A.; Valent P.; Horny H.-P.; Sotlar K.; Hartmann K.. The Journal of allergy and clinical immunology. 2015.

Long-term treatment with imatinib results in profound mast cell deficiency in Ph+ chronic myeloid leukemia

Cerny-Reiterer S.; Rabenhorst A.; Stefanzl G.; Herndlhofer S.; Hoermann G.; Mullauer L.; Baumgartner S.; Beham-Schmid C.; Sperr W.R.; Mannhalter C.; Sill H.; Linkesch W.; Arock M.; Hartmann K.; Valent P.. Oncotarget. 2015.

Subthreshold IKK activation modulates the effector functions of primary mast cells and allows specific targeting of transformed mast cells.

Drube S; Weber F; Loschinski R; Beyer M; Rothe M; Rabenhorst A; Göpfert C; Meininger I; Diamanti MA; Stegner D; Häfner N; Böttcher M; Reinecke K; Herdegen T; Greten FR; Nieswandt B; Hartmann K; Krämer OH; Kamradt T. Oncotarget. 2015.

TAK1 and IKK2, novel mediators of SCF-induced signaling and potential targets for c-Kit-driven diseases.

Drube S; Weber F; Göpfert C; Loschinski R; Rothe M; Boelke F; Diamanti MA; Löhn T; Ruth J; Schütz D; Häfner N; Greten FR; Stumm R; Hartmann K; Krämer OH; Dudeck A; Kamradt T. Oncotarget. 2015.

Cre/loxP-based mouse models of mast cell deficiency and mast cell-specific gene inactivation

Peschke K.; Dudeck A.; Rabenhorst A.; Hartmann K.; Roers A.. . 2014.

Genetic ablation of mast cells redefines the role of mast cells in skin wound healing and bleomycin-induced fibrosis.

Willenborg S; Eckes B; Brinckmann J; Krieg T; Waisman A; Hartmann K; Roers A; Eming SA. The Journal of investigative dermatology. 2014.

Interleukin-31: A novel diagnostic marker of allergic diseases

Rabenhorst A.; Hartmann K.. CURRENT ALLERGY AND ASTHMA REPORTS. 2014.

IκB Kinase 2 Is Essential for IgE-Induced Mast Cell De Novo Cytokine Production but Not for Degranulation

Peschke K.; Weitzmann A.; Heger K.; Behrendt R.; Schubert N.; Scholten J.; Voehringer D.; Hartmann K.; Dudeck A.; Schmidt-Supprian M.; Roers A.. Cell Reports. 2014.

Mast cells are activated by Staphylococcus aureus in vitro but do not influence the outcome of intraperitoneal S. aureus infection in vivo

Ronnberg E.; Johnzon C.-F.; Calounova G.; Garcia Faroldi G.; Grujic M.; Hartmann K.; Roers A.; Guss B.; Lundequist A.; Pejler G.. IMMUNOLOGY. 2014.

Proposed diagnostic algorithm for patients with suspected mastocytosis: A proposal of the European Competence Network on Mastocytosis

Valent P.; Escribano L.; Broesby-Olsen S.; Hartmann K.; Grattan C.; Brockow K.; Niedoszytko M.; Nedoszytko B.; Oude Elberink J.N.G.; Kristensen T.; Butterfield J.H.; Triggiani M.; Alvarez-Twose I.; Reiter A.; Sperr W.R.; Sotlar K.; Yavuz S.; Kluin-Nelemans H.C.; Hermine O.; Radia D.; Van Doormaal J.J.; Gotlib J.; Orfao A.; Siebenhaar F.; Schwartz L.B.; Castells M.; Maurer M.; Horny H.-P.; Akin C.; Metcalfe D.D.; Arock M.. ALLERGY. 2014.

Refined diagnostic criteria and classification of mast cell leukemia (MCL) and myelomastocytic leukemia (MML): A consensus proposal

Valent P.; Sotlar K.; Sperr W.R.; Escribano L.; Yavuz S.; Reiter A.; George T.I.; Kluin-Nelemans H.C.; Hermine O.; Butterfield J.H.; Hagglund H.; Ustun C.; Hornick J.L.; Triggiani M.; Radia D.; Akin C.; Hartmann K.; Gotlib J.; Schwartz L.B.; Verstovsek S.; Orfao A.; Metcalfe D.D.; Arock M.; Horny H.-P.. Annals of oncology : official journal of the European Society for Medical Oncology. 2014.

Targeting tumor-infiltrating B cells in cutaneous T-Cell lymphoma

Theurich S.; Schlaak M.; Steguweit H.; Heukamp L.C.; Wennhold K.; Kurschat P.; Rabenhorst A.; Hartmann K.; Schlosser H.; Shimabukuro-Vornhagen A.; Holtick U.; Hallek M.; Stadler R.; Von Bergwelt-Baildon M.. JOURNAL OF CLINICAL ONCOLOGY. 2014.

The KIT D816V expressed allele burden for diagnosis and disease monitoring of systemic mastocytosis

Erben P.; Schwaab J.; Metzgeroth G.; Horny H.-P.; Jawhar M.; Sotlar K.; Fabarius A.; Teichmann M.; Schneider S.; Ernst T.; Muller M.C.; Giehl M.; Marx A.; Hartmann K.; Hochhaus A.; Hofmann W.-K.; Cross N.C.P.; Reiter A.. Annals of hematology. 2014.

Anti-Fas/CD95 and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) differentially regulate apoptosis in normal and neoplastic human basophils

Forster A.; Falcone F.H.; Gibbs B.F.; Preussner L.M.; Fiebig B.S.; Altunok H.; Seeger J.M.; Cerny-Reiterer S.; Rabenhorst A.; Papenfuss K.; Valent P.; Kashkar H.; Hartmann K.. Leukemia & lymphoma. 2013.

Dimethylfumarate induces apoptosis in human mast cells

Forster A.; Preussner L.M.; Seeger J.M.; Rabenhorst A.; Kashkar H.; Mrowietz U.; Hartmann K.. EXPERIMENTAL DERMATOLOGY. 2013.

Hereditary angioedema due to C1 inhibitor deficiency Hereditäres Angioödem durch C1-Inhibitor-Mangel

Bork K.; Maurer M.; Bas M.; Hartmann K.; Biedermann T.; Kreuz W.; Aygoren-Pursun E.; Martinez-Saguer I.; Ott H.; Wedi B.. ALLERGOLOGIE. 2013.

International Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT) & European Competence Network on Mastocytosis (ECNM) consensus response criteria in advanced systemic mastocytosis

Gotlib J.; Pardanani A.; Akin C.; Reiter A.; George T.; Hermine O.; Kluin-Nelemans H.; Hartmann K.; Sperr W.R.; Brockow K.; Schwartz L.B.; Orfao A.; DeAngelo D.J.; Arock M.; Sotlar K.; Horny H.-P.; Metcalfe D.D.; Escribano L.; Verstovsek S.; Tefferi A.; Valent P.. Blood. 2013.

Mast cell and macrophage chemokines CXCL1/CXCL2 control the early stage of neutrophil recruitment during tissue inflammation

De Filippo K.; Dudeck A.; Hasenberg M.; Nye E.; Van Rooijen N.; Hartmann K.; Gunzer M.; Roers A.; Hogg N.. Blood. 2013.

Mast cells are dispensable for normal and activin-promoted wound healing and skin carcinogenesis

Antsiferova M.; Martin C.; Huber M.; Feyerabend T.B.; Forster A.; Hartmann K.; Rodewald H.-R.; Hohl D.; Werner S.. JOURNAL OF IMMUNOLOGY. 2013.

Perivascular Mast Cells Dynamically Probe Cutaneous Blood Vessels to Capture Immunoglobulin E

Cheng L.E.; Hartmann K.; Roers A.; Krummel M.F.; Locksley R.M.. IMMUNITY. 2013.

Selective ablation of mast cells or basophils reduces peanut-induced anaphylaxis in mice

Reber L.L.; Marichal T.; Mukai K.; Kita Y.; Tokuoka S.M.; Roers A.; Hartmann K.; Karasuyama H.; Nadeau K.C.; Tsai M.; Galli S.J.. The Journal of allergy and clinical immunology. 2013.

Serum IL-31 levels are increased in a subset of patients with mastocytosis and correlate with disease severity in adult patients

Hartmann K.; Wagner N.; Rabenhorst A.; Pflanz L.; Leja S.; Forster A.; Gehring M.; Kapp A.; Raap U.. The Journal of allergy and clinical immunology. 2013.

Serum levels of bone cytokines are increased in indolent systemic mastocytosis associated with osteopenia or osteoporosis

Rabenhorst A.; Christopeit B.; Leja S.; Gerbaulet A.; Kleiner S.; Forster A.; Raap U.; Wickenhauser C.; Hartmann K.. The Journal of allergy and clinical immunology. 2013.

Anaphylaxis to red meat: Galactose-α- 1,3-galactose (α-Gal) - An interesting allergen Anaphylaxien auf rotes fleisch: Galactose-α-1,3-galactose (α-gal) - Ein interessantes allergen

Wagner N.; Jappe U.; Podda M.; Hartmann K.. ALLERGOLOGIE. 2012.

Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: A consensus proposal

Valent P.; Akin C.; Arock M.; Brockow K.; Butterfield J.H.; Carter M.C.; Castells M.; Escribano L.; Hartmann K.; Lieberman P.; Nedoszytko B.; Orfao A.; Schwartz L.B.; Sotlar K.; Sperr W.R.; Triggiani M.; Valenta R.; Horny H.-P.; Metcalfe D.D.. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY. 2012.

European Competence Network on Mastocytosis (ECNM): 10-year jubilee, update, and future perspectives

Valent P.; Arock M.; Bonadonna P.; Brockow K.; Broesby-Olsen S.; Escribano L.; Gleixner K.V.; Grattan C.; Hadzijusufovic E.; Hagglund H.; Hermine O.; Horny H.-P.; Kluin-Nelemans H.C.; Maurer M.; Niedoszytko M.; Nedoszytko B.; Nilsson G.; Oude-Elberink H.N.G.; Orfao A.; Radia D.; Reiter A.; Siebenhaar F.; Sotlar K.; Sperr W.R.; Triggiani M.; Vandoormaal J.J.; Varkonyi J.; Yavuz S.; Hartmann K.. Wiener Klinische Wochenschrift. 2012.

Mast cells play a protumorigenic role in primary cutaneous lymphoma

Rabenhorst A.; Schlaak M.; Heukamp L.C.; Forster A.; Theurich S.; Von Bergwelt-Baildon M.; Buttner R.; Kurschat P.; Mauch C.; Roers A.; Hartmann K.. Blood. 2012.

SH2 Domain-Containing Phosphatase 2 Is a Critical Regulator of Connective Tissue Mast Cell Survival and Homeostasis in Mice

Sharma N.; Kumar V.; Everingham S.; Mali R.S.; Kapur R.; Zeng L.-F.; Zhang Z.-Y.; Feng G.-S.; Hartmann K.; Roers A.; Craig A.W.B.. Molecular and cellular biology. 2012.

Transcription factor E3, a major regulator of mast cell-mediated allergic response

Yagil Z.; Hadad Erlich T.; Ofir-Birin Y.; Tshori S.; Kay G.; Yekhtin Z.; Fisher D.E.; Cheng C.; Wong W.S.F.; Hartmann K.; Razin E.; Nechushtan H.. The Journal of allergy and clinical immunology. 2012.

Mast cell hyperplasia, B-cell malignancy, and intestinal inflammation in mice with conditional expression of a constitutively active kit

Gerbaulet A.; Wickenhauser C.; Scholten J.; Peschke K.; Drube S.; Horny H.-P.; Kamradt T.; Naumann R.; Muller W.; Krieg T.; Waskow C.; Hartmann K.; Roers A.. Blood. 2011.

Mast Cells Are Key Promoters of Contact Allergy that Mediate the Adjuvant Effects of Haptens

Dudeck A.; Dudeck J.; Scholten J.; Petzold A.; Surianarayanan S.; Kohler A.; Peschke K.; Vohringer D.; Waskow C.; Krieg T.; Muller W.; Waisman A.; Hartmann K.; Gunzer M.; Roers A.. IMMUNITY. 2011.

Mastocytosis - Diagnostic and therapeutic management Mastozytose - Diagnostisches und therapeutisches Management

Wagner N.; Hartmann K.. Aktuelle Dermatologie. 2011.

Mild recessive dystrophic epidermolysis bullosa associated with two compound heterozygous COL7A1 mutations

von Bartenwerffer W.; Has C.; Arin M.J.; Tantcheva-A-Poor I.; Kreuter A.; Kremer K.; Arshah T.; Hoffmann M.; Eming S.A.; Kohlhase J.; Krieg T.; Bruckner-Tuderman L.; Hartmann K.. EUROPEAN JOURNAL OF DERMATOLOGY. 2011.

Therapy of urticaria: German language version of the international S3-guideline Teil 2: Therapie der Urtikaria - Deutschsprachige version der internationalen S3-leitlinie

Zuberbier T.; Aberer W.; Brockow K.; Grabbe J.; Hamelmann E.; Hartmann K.; Jakob T.; Maurer M.; Merk H.F.; Ollert M.; Rueff F.; Schmid-Grendelmeier P.; Staubach P.; Voigtmann I.; Wedi B.. Allergo Journal. 2011.

A case of linear porokeratosis superimposed on disseminated superficial actinic porokeratosis

Lohrer R.; Neumann-Acikel A.; Eming R.; Hartmann K.; Rasokat H.; Krieg T.; Happle R.; Eming S.. Case reports in dermatology. 2010.

Effects of topical treatment with the raft modulator miltefosine and clobetasol in cutaneous mastocytosis: A randomized, double-blind, placebo-controlled trial

Hartmann K.; Siebenhaar F.; Belloni B.; Brockow K.; Eben R.; Hartmann B.; Rueff F.; Schoepke N.; Staubach P.; Weber A.; Maurer M.. BRITISH JOURNAL OF DERMATOLOGY. 2010.

Mastocytosis - An update Mastozytose - Aktueller Stand

Amon U.; Hartmann K.; Horny H.-P.; Nowak A.; Simon J.C.. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG. 2010.

The classification of systemic mastocytosis should include mast cell leukemia (MCL) and systemic mastocytosis with a clonal hematologic non-mast cell lineage disease (SM-AHNMD)

Valent P.; Arock M.; Akin C.; Sperr W.R.; Reiter A.; Sotlar K.; Hartmann K.; George T.I.; Brockow K.; Kluin-Nelemans H.C.; Gotlib J.; Metcalfe D.D.; Horny H.-P.. Blood. 2010.

The receptor tyrosine kinase c-Kit controls IL-33 receptor signaling in mast cells

Drube S.; Heink S.; Walter S.; Lohn T.; Grusser M.; Gerbaulet A.; Berod L.; Schons J.; Dudeck A.; Freitag J.; Grotha S.; Reich D.; Rudeschko O.; Norgauer J.; Hartmann K.; Roers A.; Kamradt T.. Blood. 2010.

Mast cells as regulators of adaptive immunity to tumours

Wasiuk A.; De Vries V.C.; Hartmann K.; Roers A.; Noelle R.J.. Clinical and experimental immunology. 2009.

Mastocytosis: Guideline of the German Society of Allergology and Clinical Immunology (DGAKI) and the German Dermatological Society (DDG) Mastozytose: Leitlinie der Deutschen Gesellschaft für Allergologie und klinische Immunologie (DGAKI) und der Deutschen Dermatologischen Gesellschaft (DDG)

Hartmann K.; Biedermann T.; Brockow K.; Grabbe J.; Horny H.-P.; Lippert U.; Maurer M.; Raithel M.; Rietschel E.; Rueff F.; Sotlar K.. Allergo Journal. 2009.

Treatment of allergic angioedema

Hartmann K. . 2009.

African tick bite fever - Papulovesicular exanthem with fever after staying in South Africa Afrikanisches zeckenbissfieber - Papulovesikuläres exanthem mit fieber nach Südafrika-aufenthalt

Schuster J.; Tantcheva-Poor I.; Wickenhauser C.; Chemnitz J.-M.; Hunzelmann N.; Krieg T.; Hartmann K.. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG. 2008.

CYLD mutations in familial skin appendage tumours

Saggar S.; Chernoff K.A.; Lodha S.; Horev L.; Kohl S.; Honjo R.S.; Brandt H.R.C.; Hartmann K.; Celebi J.T.. JOURNAL OF MEDICAL GENETICS. 2008.

Elevated levels of tryptase in children with nummular eczema

Lange L.; Rietschel E.; Hunzelmann N.; Hartmann K.. ALLERGY. 2008.

Linear livid papules on the leg in a 4-year-old child

Tantcheva-Poor I.; Hartmann K.; Mauch C.. PEDIATRIC DERMATOLOGY. 2008.

Mast cell-specific Cre/loxP-mediated recombination in vivo

Scholten J.; Hartmann K.; Gerbaulet A.; Krieg T.; Muller W.; Testa G.; Roers A.. TRANSGENIC RESEARCH. 2008.

Mastocytosis - A disease of the hematopoietic stem cell Die mastozytose: Eine erkrankung der hämopoetischen stammzelle

Horny H.-P.; Sotlar K.; Valent P.; Hartmann K.. Deutsches Arzteblatt. 2008.

Standards and standardization in mastocytosis: Consensus statements on diagnostics, treatment recommendations and response criteria

Valent P.; Akin C.; Escribano L.; Fodinger M.; Hartmann K.; Brockow K.; Castells M.; Sperr W.R.; Kluin-Nelemans H.C.; Hamdy N.A.T.; Lortholary O.; Robyn J.; Van Doormaal J.; Sotlar K.; Hauswirth A.W.; Arock M.; Hermine O.; Hellmann A.; Triggiani M.; Niedoszytko M.; Schwartz L.B.; Orfao A.; Horny H.-P.; Metcalfe D.D.. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2007.

Mast cell apoptosis.

Gerbaulet A.; Hartmann K.; Mekori Y.A.. Methods in molecular biology (Clifton, N.J.). 2006.

Pathogenic role for skin macrophages in a mouse model of keratinocyte-induced psoriasis-like skin inflammation

Stratis A.; Pasparakis M.; Rupec R.A.; Markur D.; Hartmann K.; Scharffetter-Kochanek K.; Peters T.; Van Rooijen N.; Krieg T.; Haase I.. The Journal of clinical investigation. 2006.

Novel germline mutation of KIT associated with familial gastrointestinal stromal tumors and mastocytosis

Hartmann K.; Wardelmann E.; Ma Y.; Merkelbach-Bruse S.; Preussner L.M.; Woolery C.; Baldus S.E.; Heinicke T.; Thiele J.; Buettner R.; Longley B.J.. Gastroenterology. 2005.

[Urticaria. Classification and diagnosis].

Hartmann K. Hautarzt. 2004.

Allergic contact dermatitis from cinnamon as an odour-neutralizing agent in shoe insoles

Hartmann K.; Hunzelmann N.. CONTACT DERMATITIS. 2004.

Altered apoptosis and cell cycling of mast cells in bone marrow lesions of patients with systemic mastocytosis

Baldus S.E.; Zirbes T.K.; Thiele J.; Eming S.A.; Henz B.M.; Hartmann K.. Haematologica. 2004.

The European Competence Network on Mastocytosis (ECNM)

Valent P.; Arock M.; Bischoff S.C.; Buhring H.-J.; Brockow K.; Escribano L.; Fodinger M.; Grabbe J.; Hartmann K.; Henz B.M.; Horny H.-P.; Kluin-Nelemans H.C.; Lima M.; Marone G.; Orfao A.; Parwaresch R.M.; Sillaber C.; Sotlar K.; Sperr W.R.; Triggiani M.; Van Doormaal J.J.; Wolff K.; Zuberbier T.. Wiener Klinische Wochenschrift. 2004.

Diagnosis and treatment of urticaria - Guidelines Diagnostik und therapie der urtikaria

Zuberbier T.; Aberer W.; Grabbe J.; Hartmann K.; Merk H.; Ollert M.; Rueff F.; Wedi B.; Wenning J.. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG. 2003.

Evidence for altered mast cell proliferation and apoptosis in cutaneous mastocytosis

Hartmann K.; Hermes B.; Rappersberger K.; Sepp N.; Mekori Y.A.; Henz B.M.. BRITISH JOURNAL OF DERMATOLOGY. 2003.

Expression of bcl-2 and bcl-xl in cutaneous and bone marrow lesions of mastocytosis

Hartmann K.; Artuc M.; Baldus S.E.; Zirbes T.K.; Hermes B.; Thiele J.; Mekori Y.A.; Henz B.M.. The American journal of pathology. 2003.

Ultraviolet Irradiation Induces Apoptosis in Human Immature, but Not in Skin Mast Cells

Guhl S.; Hartmann K.; Tapkenhinrichs S.; Smorodchenko A.; Grutzkau A.; Henz B.M.; Zuberbier T.. The Journal of investigative dermatology. 2003.

Classification of cutaneous mastocytosis: A modified consensus proposal (multiple letters)

Hartmann K.; Henz B.M.; Valent P.; Bennett J.M.. Leukemia research. 2002.

Cutaneous mastocytosis - Clinical heterogeneity

Hartmann K.; Henz B.M.. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY. 2002.

Expression of matrilin-2 in human skin

Piecha D.; Hartmann K.; Kobbe B.; Haase I.; Mauch C.; Krieg T.; Paulsson M.. The Journal of investigative dermatology. 2002.

Expression of mast cell growth modulating and chemotactic factors and their receptors in human cutaneous scars.

Hermes B; Welker P; Feldmann-Böddeker I; Krüger-Krasagakis S; Hartmann K; Zuberbier T; Henz BM. The Journal of investigative dermatology. 2001.

Expression of monocyte chemoattractant protein-1 in the lesional skin of systemic sclerosis

Yamamoto T.; Eckes B.; Hartmann K.; Krieg T.. JOURNAL OF DERMATOLOGICAL SCIENCE. 2001.

Human mast cell apoptosis is regulated through Bcl-2 and Bcl-XL

Mekori Y.A.; Gilfillan A.M.; Akin C.; Hartmann K.; Metcalfe D.D.. Journal of clinical immunology. 2001.

Lichenoid chronic graft-versus-host disease-like acrodermatitis induced by hydroxyurea [5]

Eming S.A.; Peters T.; Hartmann K.; Scharffetter-Kochanek K.; Mahrle G.. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 2001.

Mastocytosis: Recent advances in defining the disease

Hartmann K.; Henz B.M.. BRITISH JOURNAL OF DERMATOLOGY. 2001.

Mastocytosis: Review of Clinical and Experimental Aspects

Hartmann K.; Bruns S.B.; Henz B.. JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS. 2001.

Role of stem cell factor and monocyte chemoattractant protein-1 in the interaction between fibroblasts and mast cells in fibrosis

Yamamoto T.; Hartmann K.; Eckes B.; Krieg T.. JOURNAL OF DERMATOLOGICAL SCIENCE. 2001.

Successful sulfasalazine treatment of severe chronic idiopathic urticaria associated with pressure urticaria [13]

Hartmann K.; Hani N.; Hinrichs R.; Hunzelmann N.; Scharffetter-Kochanek K.. ACTA DERMATO-VENEREOLOGICA. 2001.

Treatment of physical urticaria: Antihistamines and alternative approaches Therapie der physikalischen urtikaria: Antihistaminika und alternativen

Henz B.M.; Hartmann K.; Hermes B.. ALLERGOLOGIE. 2001.

Biogenic amines Biogene amine

Hartmann K.. Aktuelle Dermatologie. 2000.

Improvement of cold urticaria by treatment with the leukotriene receptor antagonist montelukast [17]

Hani N.; Hartmann K.; Casper C.; Peters T.; Schneider L.-A.; Hunzelmann N.; Scharffetter-Kochanek K.. ACTA DERMATO-VENEREOLOGICA. 2000.

Mast cells enhance contraction of three-dimensional collagen lattices by fibroblasts by cell-cell interaction: Role of stem cell factor/c-kit

Yamamoto T.; Hartmann K.; Eckes B.; Krieg T.. IMMUNOLOGY. 2000.

Monocyte chemoattractant protein-1 enhances gene expression and synthesis of matrix metalloproteinase-1 in human fibroblasts by an autocrine IL-1α loop

Yamamoto T.; Eckes B.; Mauch C.; Hartmann K.; Krieg T.. JOURNAL OF IMMUNOLOGY. 2000.

Pediatric mastocytosis

Hartmann K.; Metcalfe D.D.. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA. 2000.

Regulation and dysregulation of mast cell survival and apoptosis

Hartmann K; Metcalfe DD. . 2000.

A patient with acanthosis nigricans, obesity, insulin resistance, hypothyroidism and atopic dermatitis. Conditional or incidental coincidence?

Hartmann K.; Even G.. H+G: Zeitschrift für Hautkrankheiten. 1999.

Mast cell apoptosis and its regulation

Mekori YA; Hartmann K; Metcalfe DD. . 1999.

Expression and functional activity of the IL-8 receptor type CXCR1 and CXCR2 on human mast cells

Lippert U.; Artuc M.; Grutzkau A.; Moller A.; Kenderessy-Szabo A.; Schadendorf D.; Norgauer J.; Hartmann K.; Schweitzer-Stenner R.; Zuberbier T.; Henz B.M.; Kruger-Krasagakes S.. JOURNAL OF IMMUNOLOGY. 1998.

Fas ligand (FasL, CD95L, APO-1L) expression in murine mast cells

Wagelie-Steffen A.L.; Hartmann K.; Vliagoftis H.; Metcalfe D.D.. IMMUNOLOGY. 1998.

C3a and C5a stimulate chemotaxis of human mast cells

Hartmann K.; Henz B.M.; Kruger-Krasagakes S.; Kohl J.; Burger R.; Gurtl S.; Haase I.; Lippert U.; Zuberbier T.. Blood. 1997.

Enhanced P-Selectin Expression in Chronic and Dermographic Urticaria

Zuberbier T.; Schadendorf D.; Haas N.; Hartmann K.; Henz B.M.. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY. 1997.

Fas (CD95, APO-1) Antigen Expression and Function in Murine Mast Cells

Hartmann K.; Wagelie-Steffen A.L.; Von Stebut E.; Metcalfe D.D.. JOURNAL OF IMMUNOLOGY. 1997.

Histamine releasability of basophils and skin mast cells in chronic urticaria

Zuberbier T.; Schwarz S.; Hartmann K.; Pfrommer C.; Czarnetzki B.M.. ALLERGY. 1996.

Effect of CC chemokines on mediator release from human skin mast cells and basophils

Hartmann K.; Beiglbock F.; Czarnetzki B.M.; Zuberbier T.. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY. 1995.

Gangliosides enhance IgE receptor-dependent histamine and LTC4 release from human mast cells

Zuberbier T.; Pfrommer C.; Beinholzl J.; Hartmann K.; Ricklinkat J.; Czarnetzki B.M.. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH. 1995.

Pseudoallergen-free diet in the treatment of chronic urticaria. A prospective study

Zuberbier T.; Chantraine-Hess S.; Hartmann K.; Czarnetzki B.M.. ACTA DERMATO-VENEREOLOGICA. 1995.